Teva Hit With Investor Suit Over $40.5B Actavis Merger
A proposed class of investors in Teva Pharmaceutical Industries Ltd. slapped the drugmaker and several of its current and former executives with a suit in Pennsylvania federal court on Wednesday accusing...To view the full article, register now.
Already a subscriber? Click here to view full article